Document is current
Any future updates will be listed below
-
Authors
Shimazu, Yutaka https://orcid.org/0000-0002-1604-7220
Kanda, Junya https://orcid.org/0000-0002-6704-3633
Onda, Yoshiyuki https://orcid.org/0000-0003-3093-4974
Fuchida, Shin-ichi https://orcid.org/0000-0002-4147-9113
Ohta, Kensuke
Shimura, Yuji https://orcid.org/0000-0001-9309-7902
Kosugi, Satoru https://orcid.org/0000-0001-9057-5761
Yamamura, Ryosuke
Matsuda, Mitsuhiro https://orcid.org/0000-0002-4068-166X
Hanamoto, Hitoshi
Adachi, Yoko
Anzai, Naoyuki
Hotta, Masaaki
Fukushima, Kentaro
Yagi, Hideo
Yoshihara, Satoshi
Tanaka, Yasuhiro https://orcid.org/0000-0001-7889-3097
Takakuwa, Teruhito
Tanaka, Hirokazu
Shibayama, Hirohiko
Uoshima, Nobuhiko
Hosen, Naoki
Ito, Tomoki https://orcid.org/0000-0001-5419-9156
Shimazaki, Chihiro https://orcid.org/0000-0002-1006-7749
Matsumura, Itaru https://orcid.org/0000-0003-2818-4270
Kuroda, Junya
Takaori-Kondo, Akifumi
Hino, Masayuki
- License Information
-
More Information
Article History
Received: 14 February 2024
Accepted: 20 April 2024
First Online: 17 May 2024
Declarations
:
: Shin-ichi Fuchida has received honoraria from Takeda, Sanofi, Janssen, Ono, Bristol-Myers Squibb. Tomoki Ito has received honoraria from Bristol-Myers Squibb and Sanofi, Grant/Research funding from Bristol-Myers Squibb. Yuji Shimura has received honoraria from Bristol-Myers Squibb, Janssen Pharmaceutical and Sanofi. Teruhito Takakuwa has received honoraria from Bristol-Myers Squib and Grant/Research funding from Janssen Pharmaceutical and Sanofi. Hirohiko Shibayama reports honoraria from Takeda, Ono, Fujimoto, Janssen, Chugai, Eisai, Sanofi, AstraZeneca, Meiji Seika Pharma, and AbbVie. Chihiro Shimazaki has received honoraria from Janssen, Bristol-Myers Squibb, and Sanofi. Junya Kuroda is a consultant for Janssen Pharmaceutical and Bristol-Myers Squibb (BMS), and has received honoraria from Janssen Pharmaceutical, Ono Pharmaceutical, Sanofi, and BMS. The other authors have no conflict of interest.
: Not applicable.
: All procedures involving patients performed in this study were in accordance with the ethical standards of the Ethics Committee of the Kyoto University Graduate School and Faculty of Medicine (approval no. R2887; approval date: January 6th, 2022) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The informed consent requirement for this retrospective study was waived because the study was conducted retrospectively and the opportunity to refuse was guaranteed.
